March 2026
The global infectious disease diagnostics market size is expected to reach around USD 71.06 billion by 2035 from USD 35.39 billion in 2025 with a CAGR of 7.22%.
January 2026
The global point-of-care infectious disease diagnostics market size is projected to hit around USD 25.66 billion by 2035, with a CAGR of 15.26% from 2026 to 2035.
September 2026
The global infectious disease molecular diagnostics market size is estimated to hit around USD 63.37 billion by 2034 with a CAGR of 3.25% from 2026 to 2034.
September 2026
The infectious respiratory disease diagnostics market size was USD 60.62 billion in 2026, with leading infectious respiratory disease diagnostics market players including F. Hoffmann - La Roche, Thermo Fisher Scientific, Danaher (Cepheid), Abbott LaboratoriesÂ
January 2026
The infectious disease in-vitro diagnostics market size is valued at USD 28.10 billion in 2025 and is expected to hit around USD 35.68 billion by 2035, growing at a CAGR of 2.42%.
September 2026
The global sexually transmitted diseases diagnostics market size is estimated to hit around USD 21.44 billion by 2034 from USD 12.26 billion in 2026, with a CAGR of 7.24%.
September 2026
The global Alzheimers disease diagnostics market size was evaluated at USD 10.42 billion in 2026 and is predicted to hit around USD 26.21 billion by 2035, growing at a CAGR of 10.80%.
August 2026
The infectious disease vaccines market size reached USD 41.60 billion in 2026, with leading infectious disease vaccines market companies including Pfizer, Moderna, Johnson & Johnson (Janssen), GlaxoSmithKline (GSK).
November 2025
The infectious disease therapeutics market size is calculated at USD 36.22 billion in 2025 and is expected to hit around USD 53.48 billion by 2035 at a CAGR of 3.97%.
August 2025
The global antibody ELISA kits for tropical infectious disease market size was valued at USD 2.39 billion in 2024 and is expected to hit around USD 4.41 billion by 2034, growing at a CAGR of 6.32%.
July 2025
The global in-vitro inflammatory bowel disease diagnostics market size was valued at USD 1.74 billion in 2024 and is expected to hit around USD 3.02 billion by 2034, at a CAGR of 5.64%.
January 2025
The U.S. point of care infectious disease testing market size is projected to hit around USD 5.27 billion by 2035, growing at a CAGR of 8.98% from 2026 to 2035.
September 2026
The infectious disease immunoassay market size stood at USD 3.22 billion in 2026, with major infectious disease immunoassay market companies including Abbott Laboratories, F. Hoffmann-La Roche Ltd, bioMérieux SA, Siemens Healthineers AG, Beckman Coulter, Inc.
September 2026
The epigenetics diagnostics market size was evaluated at USD 22.40 billion in 2026 and is predicted to worth around USD 67.26 billion by 2034, with a CAGR of 14.81%.
September 2026
The global point-of-care diagnostics market size is exhibited at USD 65.94 billion in 2026 and is predicted to be worth around USD 85.03 billion by 2035 with a CAGR of 2.87%.
September 2026
The global inflammatory bowel disease treatment market size is projected to hit around USD 32.46 billion by 2035 from USD 22.38 billion in 2025, with a CAGR of 3.79%.
September 2026
The global blood cancer diagnostics market size is estimated to hit around USD 22.55 billion by 2035 increasing from USD 12.46 billion in 2026, with a CAGR of 6.83%.
September 2026
The global prostate cancer diagnostics market size is expected to hit around USD 18 billion by 2035 from USD 10.34 billion in 2026 , with a CAGR of 6.36%.
September 2026
The global cardiac AI monitoring and diagnostics market size was evaluated at USD 5.17 billion in 2026 and is predicted to hit around USD 18.89 billion by 2035, growing at a CAGR of 15.48%.
September 2026
The artificial intelligence in diagnostics market size was calculated at USD 2.33 billion in 2026 and is projected to hit around USD 11.82 billion by 2035 with a CAGR of 19.81%.
September 2026
The global in vitro diagnostics (IVD) market size accounted for USD 106.16 billion in 2026 and is expected to reach USD 135.76 billion by 2035.
September 2026
The global cancer diagnostics market size was exhibited at USD 184.96 billion in 2026 and is predicted to surpass around USD 378.44 billion by 2035 with a CAGR of 8.33%.
September 2026
The lyme disease diagnostic devices market size accounted for USD 2.97 billion in 2026 and is predicted to hit around USD 4.79 billion by 2035, with a CAGR of 5.44%.
September 2026
The global paper diagnostics market size is expected to increase from USD 19.65 billion in 2026 and is expected to attain around USD 31.80 billion by 2034 with a CAGR of 6.20%.
September 2026
The global periodontal disease treatment market size was evaluated at USD 3.17 billion in 2026 and is predicted to hit around USD 6.23 billion by 2035, growing at a CAGR of 7.80%.
September 2026
The global enteric disease testing market size was evaluated at USD 4.58 billion in 2026 and is predicted to hit around USD 8.09 billion by 2035, growing at a CAGR of 6.52%.
September 2026
The global inflammatory disease market size was evaluated at USD 133.50 billion in 2026 and is predicted to hit around USD 241.34 billion by 2035, growing at a CAGR of 6.80%.
September 2026
The parkinsons disease biomarkers market size reached USD 1.54 billion in 2026, with leading parkinsons disease biomarkers market companies including F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Thermo Fisher Scientific, Abbott Laboratories.
September 2026
The multiple sclerosis diagnostics market size was USD 6.20 billion in 2026, with leading multiple sclerosis diagnostics market players including F. Hoffmann-La Roche Ltd., Siemens Healthineers, GE HealthCare, Thermo Fisher Scientific.
September 2026
The global Huntingtons disease market size was evaluated at USD 1.66 billion in 2026 and is predicted to hit around USD 6.48 billion by 2035, growing at a CAGR of 17.20%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com